EIM
LJPC

Essex Investment Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Essex Investment Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-231,333
Closed -$985K – 518
2020
Q2 		$985K Buy
+231,333
New +$1.41M 0.16% 198
2017
Q2 		– Sell
-16,181
Closed -$483K – 397
2017
Q1 		$483K Buy
+16,181
New +$413K 0.08% 265

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Essex Investment Management's LJPC Position: Q3 2020 in Review

Essex Investment Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2020, closing a stake of 231,333 shares — an estimated $985K sold.

Essex Investment Management first reported a position in LJPC in Q1 2017 and held it in 2 quarters. The position peaked at $985K in Q2 2020. 64 funds tracked by Wall St. Rank hold LJPC as of Q3 2020.

  • Essex Investment Management reported no remaining La Jolla Pharmaceutical Company position as of Q3 2020 after selling out during the quarter.
  • Essex Investment Management sold 231,333 La Jolla Pharmaceutical Company shares in Q3 2020, an estimated $985K.
  • Essex Investment Management first reported a position in La Jolla Pharmaceutical Company in Q1 2017 and held it in 2 quarters.
  • Essex Investment Management's La Jolla Pharmaceutical Company position peaked at $985K in Q2 2020.
  • 64 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2020.

Based on Essex Investment Management's 13F filing for Q3 2020, filed 12 Nov 2020.